Podchaser Logo
Home
Clinical Perspective Roundtable DiscussionEpisode from the podcastClinical Perspective Roundtable Discussion
Next Episode
Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two leading oral antidiabetic.

Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two leading oral antidiabetic.

Released Monday, 27th March 2023
Good episode? Give it some love!
Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two leading oral antidiabetic.

Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two leading oral antidiabetic.

Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two leading oral antidiabetic.

Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two leading oral antidiabetic.

Monday, 27th March 2023
Good episode? Give it some love!
Rate Episode
About
InsightsPodchaser Pro
Reviews
Credits
Lists
Transcript

Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two leading oral antidiabetic.

This podcast is sponsored by Novo Nordisk, Inc. and is intended for clinicians.

Show More
Rate
Get this podcast via API

From The Podcast

Clinical Perspective Roundtable Discussion

Episode 1: Hear Davida Kruger, NP and Julio Rosenstock, MD discuss important head-to-head data between a GLP-1 RA and DPP-4 inhibitor as an important consideration when making clinical decisions for patients with T2D.Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two oral antidiabetic therapies.Episode 3: Hear this clinical panel share a quick overview of the patient support resources available to help patients with T2D get off to a successful start with this GLP-1 RA treatment option.This podcast is sponsored by Novo Nordisk Inc. and is intended for clinicians.

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features
Podchaser Logo

Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More